Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1751
| Despition | HAGH Human Recombinant |
| SIZE | 2 µg |
| Purity | > 95% (SDS-PAGE) |
| Form | Sterile Filtered clear solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1208 | beta Catenin Blocking Peptide (AC1208) | 250 µg | inquiry |
| ACPP-1573 | Human YWHAG Protein, His (AC1573) | 2 µg | inquiry |
| ACPP-1404 | Human p59-Fyn Protein (AC1404) | 2 µg | inquiry |
| ACPP-1793 | Human HSPB8 Protein, His (AC1793) | 2 µg | inquiry |
| ACPP-1339 | MRAP2 Blocking Peptide (AC1339) | 250 µg | inquiry |
| ACPP-1454 | Human PICK1 Protein (AC1454) | 2 µg | inquiry |
| ACPP-1642 | ENPP2 Blocking Peptide (AC1642) | 250 µg | inquiry |
| ACPP-1574 | Human NDUFS4 Protein (AC1574) | 5 µg | inquiry |
| ACPP-1171 | Recombinant Human KCNK9 Protein (Fc Tag) (AC1171) | 50 µg | inquiry |
| ACPP-1396 | Human PON2 Protein (AC1396) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.